Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer science

Showing results (451-460 of 7,109) with videos related to

Pageof 711
Sort By:
Cancer Science|July 18, 2022
Tumor microenvironmental 15-PGDH depletion promotes fibrotic tumor formation and angiogenesis in pancreatic cancerLuke Bu, Atsuko Yonemura, Noriko Yasuda-Yoshihara, et al.
Cancer Science|July 18, 2022
Clinical significance and immune landscape of KIR2DL4 and the senescence-based signature in cutaneous melanomaRui Mao, Zhengyun Ren, Fan Yang, et al.
Cancer Science|July 18, 2022
N4BP3 promotes angiogenesis in hepatocellular carcinoma by binding with KAT2BHexu Han, Wei Zhu, Ting Lin, et al.
Cancer Science|July 25, 2022
Expert panel consensus recommendations on the use of circulating tumor DNA assays for patients with advanced solid tumorsMitsuho Imai, Yoshiaki Nakamura, Kuniko Sunami, et al.
Cancer Science|July 25, 2022
LRFN2 binding to NMDAR inhibits the progress of ESCC via regulating the Wnt/β-Catenin and NF-κB signaling pathwayYu Zhou, Lijuan Xu, Jiru Wang, et al.
Cancer Science|July 18, 2022
Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumabShuhei Takahashi, Shintaro Narita, Nobuhiro Fujiyama, et al.
Cancer Science|June 13, 2019
Interleukin-6 production mediated by the IRE1-XBP1 pathway confers radioresistance in human papillomavirus-negative oropharyngeal carcinomaXintong Lyu, Miao Zhang, Guangqi Li, et al.
Cancer Science|June 13, 2019
Significant epitranscriptomes in heterogeneous cancerMasamitsu Konno, Masateru Taniguchi, Hideshi Ishii
Cancer Science|October 10, 2019
Reduction in HPV16/18 prevalence among young women with high-grade cervical lesions following the Japanese HPV vaccination programKoji Matsumoto, Nobuo Yaegashi, Takashi Iwata, et al.
Cancer Science|July 3, 2019
Osimertinib for Japanese patients with T790M-positive advanced non-small-cell lung cancer: A pooled subgroup analysisTomonori Hirashima, Miyako Satouchi, Toyoaki Hida, et al.
Pageof 711

Showing results (451-460 of 7,109) with videos related to

Sort By:
Pageof 711
Cancer Science|July 18, 2022
Tumor microenvironmental 15-PGDH depletion promotes fibrotic tumor formation and angiogenesis in pancreatic cancerLuke Bu, Atsuko Yonemura, Noriko Yasuda-Yoshihara, et al.
Cancer Science|July 18, 2022
Clinical significance and immune landscape of KIR2DL4 and the senescence-based signature in cutaneous melanomaRui Mao, Zhengyun Ren, Fan Yang, et al.
Cancer Science|July 18, 2022
N4BP3 promotes angiogenesis in hepatocellular carcinoma by binding with KAT2BHexu Han, Wei Zhu, Ting Lin, et al.
Cancer Science|July 25, 2022
Expert panel consensus recommendations on the use of circulating tumor DNA assays for patients with advanced solid tumorsMitsuho Imai, Yoshiaki Nakamura, Kuniko Sunami, et al.
Cancer Science|July 25, 2022
LRFN2 binding to NMDAR inhibits the progress of ESCC via regulating the Wnt/β-Catenin and NF-κB signaling pathwayYu Zhou, Lijuan Xu, Jiru Wang, et al.
Cancer Science|July 18, 2022
Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumabShuhei Takahashi, Shintaro Narita, Nobuhiro Fujiyama, et al.
Cancer Science|June 13, 2019
Interleukin-6 production mediated by the IRE1-XBP1 pathway confers radioresistance in human papillomavirus-negative oropharyngeal carcinomaXintong Lyu, Miao Zhang, Guangqi Li, et al.
Cancer Science|June 13, 2019
Significant epitranscriptomes in heterogeneous cancerMasamitsu Konno, Masateru Taniguchi, Hideshi Ishii
Cancer Science|October 10, 2019
Reduction in HPV16/18 prevalence among young women with high-grade cervical lesions following the Japanese HPV vaccination programKoji Matsumoto, Nobuo Yaegashi, Takashi Iwata, et al.
Cancer Science|July 3, 2019
Osimertinib for Japanese patients with T790M-positive advanced non-small-cell lung cancer: A pooled subgroup analysisTomonori Hirashima, Miyako Satouchi, Toyoaki Hida, et al.
Pageof 711